Vaccine News and Research

Latest Vaccine News and Research

What are coronaviruses and COVID-19?

The current COVID-19 pandemic is caused by a novel coronavirus called SARS-CoV-2, or severe acute respiratory syndrome coronavirus 2. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2.

1 Apr 2020

Putting an end to the pandemic

From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.

1 Apr 2020

Phoseon’s KeyPro products use high-intensity UV light to fight against pathogens

Phoseon’s KeyPro™ family of products uses high-intensity, deep ultraviolet light to disinfect and decontaminate laboratory equipment and surfaces. Independent testing has shown efficacy of KeyPro against viruses, bacteria, fungi, and biomolecules like ribonuclease.

From Phoseon Technology 1 Apr 2020

Blood centers will collect plasma from COVID-19 survivors in bid for treatment

Blood donation centers across the U.S. are ramping up efforts to collect plasma from people who have recovered from COVID-19 in hopes it could be used to save the lives of others infected with the pandemic disease.

1 Apr 2020

Purdue scientists working to speed up diagnostic, therapeutic solutions for COVID-19

As the coronavirus pandemic spreads across the U.S. and the world, Purdue University scientists are working to move solutions to diagnose and treat the virus to the marketplace as soon as possible.

1 Apr 2020

Spit and feces test positive for SARS CoV-2 even after recovery

A new study reveals that samples of sputum and feces continue to test positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus even after a person has recovered from COVID-19 and nasopharyngeal secretions test negative for the virus.

31 Mar 2020

UM receives funding for research center dedicated to addressing public health challenges

As emergent pathogens like coronavirus and climate-related health challenges like wildfire smoke plague human populations, the University of Montana has received funding for a center dedicated to understanding and addressing public health challenges to Montana and the region.

31 Mar 2020

Novel, affordable pneumonia vaccine tested in human patients

A novel vaccine against pneumonia that is less expensive and more effective than those currently used in Brazil is being tested in human patients.

31 Mar 2020

Virus-scanning tool could identify previously undetected cases of COVID-19 infections

When a virus invades the body, it leaves fingerprints behind. A research tool known as VirScan can detect this evidence - from just a single drop of blood - and identify the viruses that have infected a person in the past. Soon, the new coronavirus will join the VirScan lineup.

31 Mar 2020

Three Australian experts explain the course of COVID-19

Researchers have been studying the ongoing pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) closely since its beginning in December 2019. To date, the virus has infected over 850,000 individuals across the globe and killed over 41,000.

31 Mar 2020

Cobra Biologics and Karolinska Institutet join forces to develop DNA vaccine against COVID-19

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet, one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic.

31 Mar 2020

Online coronavirus tests are just the latest iffy products marketed to anxious consumers

Companies with experience in the "at-home" testing market began announcing in mid-March that they would be offering direct-to-consumer test kits for COVID-19.

31 Mar 2020

Eight strains of coronavirus afflicting the world

Scientists around the world are racing to study the novel coronavirus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, it appears that there are eight strains of SARS-CoV-2 circulating the globe. The good news is that according to infectious disease physician and clinical microbiologist Charles Chiu, “The virus mutates so slowly that the virus strains are fundamentally very similar to each other.”

31 Mar 2020

UAB will collaborate with Altimmune to test a COVID-19 vaccine candidate

The University of Alabama at Birmingham is launching a collaboration with the biopharmaceutical company Altimmune, Inc. for preclinical testing of a potential vaccine to prevent COVID-19 disease.

30 Mar 2020

How long to a coronavirus vaccine?

The whole world is waiting for one. A vaccine is the only thing that could conceivably save the world from a horrifying cascade of deaths, other than a miracle, it seems.

29 Mar 2020

Will 'old faithful' tuberculosis BCG vaccine work against COVID?

All over the world, except in China, the place where it all began, the COVID-19 pandemic is making its relentless way through the population. So far, it has caused nearly 34,000 deaths – and the situation in the US is still worsening with over 142,000 cases and 2,489 deaths. In Australia, the number of cases has climbed to 4,093, with 16 fatalities.

29 Mar 2020

New test uses saliva sample to provide immediate hepatitis B diagnosis

Viruses are sneaky beings. As the coronavirus pandemic is demonstrating, they cross borders quickly and can be highly contagious before symptoms of disease break out. In many cases of infection, a clear path of transmission cannot be determined.

27 Mar 2020

Research offers hope for increasing the robustness of vaccine response in older people

Research just published by the Linterman lab shows that the immune system of older mice can be given a helping hand by applying immunology expertise and some genital wart treatment (don't try this at home just yet)!

27 Mar 2020

Disasters have a major impact on cervical cancer screening for years

Cervical cancer screening rates in Japan were significantly affected in the years following the devastating Great East Japan Earthquake of 2011, Tohoku University scientists report in the journal PLOS ONE.

27 Mar 2020

Microbiome could help identify pre-cancer risk in women with HPV

A new study published in the open-access journal PLOS Pathogens in March 2020 reports the possible use of the bacteria Gardnerella found in the cervix and vagina of women with Human papillomavirus (HPV) infection, as a marker of precancerous change. The findings could help to find new methods of treatment that involve inducing changes in the microbiome to arrest the course of the disease.

26 Mar 2020